LeonardPJamesMDPhD
Oncology • Fresh Meadows, NYHematologic Oncology, Thoracic Cancer
Senior Director, Clinical Research, Pfizer Oncology
Dr. James is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
17660 Union Tpke
Ste 360
Fresh Meadows, NY 11366Phone+1 718-460-2300
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2005 - 2008
University of ChicagoResidency, Internal Medicine, 2002 - 2005
University of Washington School of MedicineClass of 2002
Certifications & Licensure
NY State Medical License 2005 - 2026
IL State Medical License 2002 - 2005
Publications & Presentations
PubMed
- 1 citationsResponse to "Lorlatinib Exposed: A Far from Optimal Dose".Joseph Chen, Ana Ruiz-Garcia, Leonard P James, Gerson Peltz, Holger Thurm
Clinical Pharmacology and Therapeutics. 2022-06-01 - 19 citationsLorlatinib Exposure-Response Analyses for Safety and Efficacy in a Phase I/II Trial to Support Benefit–Risk Assessment in Non-Small Cell Lung CancerJoseph Chen, Ana Ruiz-Garcia, Leonard P. James, Gerson Peltz, Holger Thurm
Clinical Pharmacology and Therapeutics. 2021-11-01 - Correction to: The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants.Joseph Chen, Huiping Xu, Sylvester Pawlak, Leonard P James, Gerson Peltz
Advances in Therapy. 2020-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
